The authors proposed that S1P pathway might represent a potential target for future treatment of gestational diseases such as preeclampsia that is characterized by inadequate dNK/trophoblast-coordinated uterine spiral artery remodeling [11]. Here, MBTPS1 is linked to preeclampsia.